These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 6134397

  • 21. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
    Contraşiu P, Calinici V.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
    [No Abstract] [Full Text] [Related]

  • 22. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW, Lamers CB.
    Ned Tijdschr Geneeskd; 1989 Apr 01; 133(13):657-62. PubMed ID: 2566125
    [No Abstract] [Full Text] [Related]

  • 23. [Multi-center double-blind clinical trial of ranitidine in the treatment of stomach and duodenal ulcers].
    Gibiński K, Nowak A, Gabrylewicz A, Laszewicz W, Hasik J, Klincewicz H, Pokora J, Czarnecki J, Kosecki J, Pachlewski J.
    Pol Arch Med Wewn; 1982 Apr 01; 68(3):117-24. PubMed ID: 6133269
    [No Abstract] [Full Text] [Related]

  • 24. Cimetidine and ranitidine in duodenal ulcer.
    Langman MJ, Henry DA, Bell GB, Burnham WR, Ogilvy A.
    Br Med J; 1980 Aug 16; 281(6238):473-4. PubMed ID: 6107154
    [Abstract] [Full Text] [Related]

  • 25. Peptic ulcer in the Royal Navy.
    Hunt RH.
    J R Nav Med Serv; 1981 Aug 16; 67(3):125-30. PubMed ID: 6121054
    [No Abstract] [Full Text] [Related]

  • 26. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW.
    Am J Gastroenterol; 1987 Dec 16; 82(12):1242-9. PubMed ID: 2891294
    [Abstract] [Full Text] [Related]

  • 27. H2-blockers: how safe and how effective?
    Spiro HM.
    J Clin Gastroenterol; 1983 Dec 16; 5 Suppl 1():143-7. PubMed ID: 6140282
    [Abstract] [Full Text] [Related]

  • 28. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr 16; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 29. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr 16; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 30. [Which drug for peptic ulcer?].
    Hameeteman W, Tytgat GN.
    Ned Tijdschr Geneeskd; 1985 Aug 31; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract] [Full Text] [Related]

  • 31. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P, Ghiorzi A, Cereda E, Donetti A.
    Pharmacology; 1985 Aug 31; 30(1):45-51. PubMed ID: 2858110
    [Abstract] [Full Text] [Related]

  • 32. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
    Meryn S, Pötzi R, Brunner H, Pesendorfer FX, Pamperl H.
    Wien Klin Wochenschr; 1983 Apr 29; 95(9):310-2. PubMed ID: 6137111
    [Abstract] [Full Text] [Related]

  • 33. Use and abuse of H2 receptor antagonists.
    Hunt RH.
    J R Coll Physicians Lond; 1982 Jan 29; 16(1):33-9. PubMed ID: 6121053
    [No Abstract] [Full Text] [Related]

  • 34. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H, Arnold R.
    Dtsch Med Wochenschr; 1988 Mar 31; 113(13):516-8. PubMed ID: 2894969
    [No Abstract] [Full Text] [Related]

  • 35. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC.
    Acta Gastroenterol Belg; 1992 Mar 31; 55(5-6):415-22. PubMed ID: 1363166
    [Abstract] [Full Text] [Related]

  • 36. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report.
    Nowak A, Sadliński C, Górka Z, Nowakowska E, Rudzki J, Gibiński K.
    Hepatogastroenterology; 1981 Oct 31; 28(5):267-9. PubMed ID: 6124495
    [Abstract] [Full Text] [Related]

  • 37. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May 31; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 38. Placebo controlled studies with ranitidine in duodenal ulcer.
    Dobrilla G, Barbara L, Bianchi Porro G, Felder M, Mazzacca G, Miglioli L, Pera A, Petrillo M, Sabbatini F, Verme G.
    Scand J Gastroenterol Suppl; 1981 Jun 31; 69():101-7. PubMed ID: 6119771
    [Abstract] [Full Text] [Related]

  • 39. Histamine H2-receptor antagonists.
    Feldman M, Richardson CT.
    Adv Intern Med; 1978 Jun 31; 23():1-24. PubMed ID: 24327
    [Abstract] [Full Text] [Related]

  • 40. H2-receptor antagonists in perspective.
    Malagelada JR, Cortot A.
    Mayo Clin Proc; 1978 Mar 31; 53(3):184-90. PubMed ID: 24155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.